SB1889 amends the Illinois Vehicle Code to clarify and tighten the cannabis-related driving under the influence standard. The bill states that a person may not drive or be in actual physical control of a vehicle within two hours of driving if they have a free tetrahydrocannabinol (THC) concentration at or above 5 nanograms per milliliter in whole blood, or 10 nanograms per milliliter in another bodily substance other than urine. It also defines “free tetrahydrocannabinol concentration” as the amount of parent delta-9-THC detected in the sample, and it makes conforming changes throughout the DUI and chemical-testing provisions.
The bill also updates evidentiary rules in Section 11-501.2 so that cannabis test results can be used in DUI prosecutions and creates presumptions tied to the free-THC thresholds. It preserves the existing exception for lawful medical cannabis patients with a valid registry card unless they are impaired. In addition, the bill retains and cross-references existing rules on chemical testing, roadside chemical tests, field sobriety tests, refusal evidence, and mandatory testing in serious injury or fatal crash cases, while making technical and definitional changes to align the statute with the new THC language.
Impact
SB1889 would change Illinois DUI law by expressly basing the cannabis impairment threshold on “free” THC rather than an unspecified THC concentration, which could affect how blood and bodily-substance test results are interpreted in criminal prosecutions. It would also amend the chemical-testing statute to define the relevant THC measure and to create or clarify presumptions of impairment at the stated nanogram levels. The bill primarily affects drivers, law enforcement, prosecutors, defense counsel, forensic laboratories, and medical cannabis patients, while leaving the broader DUI penalty structure in place.
Sentiment
The available record shows no committee transcript and no recorded votes, so there is no documented floor or committee debate to gauge formal support or opposition. Based on the bill text, the measure appears aimed at clarifying enforcement of cannabis-impaired driving laws rather than expanding penalties, which suggests a public-safety and evidentiary rationale. The absence of recorded action means sentiment cannot be measured from votes, but the proposal is framed in technical and clarifying terms.
Contention
The main point of contention is likely the choice of a per se THC threshold and, more specifically, the decision to specify “free tetrahydrocannabinol concentration” as the operative measure. That issue can matter because THC testing and impairment science are often disputed, and the bill’s thresholds may be viewed by some as providing clearer enforcement standards while others may see them as imperfect proxies for actual impairment. Another likely issue is the continued treatment of lawful medical cannabis use: the bill preserves a defense for qualifying patients only if they are not impaired, which may be seen as balancing patient rights against roadway safety.
Relating to the creation of a grant program to assist local law enforcement agencies in testing certain substances suspected of containing delta-9 tetrahydrocannabinol.